These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8257632

  • 1. Activation of the human immunodeficiency virus type 1 long terminal repeat by BTEB, a GC box-binding transcription factor.
    Imataka H, Mizuno A, Fujii-Kuriyama Y, Hayami M.
    AIDS Res Hum Retroviruses; 1993 Sep; 9(9):825-31. PubMed ID: 8257632
    [Abstract] [Full Text] [Related]

  • 2. Two regulatory proteins that bind to the basic transcription element (BTE), a GC box sequence in the promoter region of the rat P-4501A1 gene.
    Imataka H, Sogawa K, Yasumoto K, Kikuchi Y, Sasano K, Kobayashi A, Hayami M, Fujii-Kuriyama Y.
    EMBO J; 1992 Oct; 11(10):3663-71. PubMed ID: 1356762
    [Abstract] [Full Text] [Related]

  • 3. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
    Maciaszek JW, Talmage DA, Viglianti GA.
    J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
    [Abstract] [Full Text] [Related]

  • 4. Transcription of the human immunodeficiency virus type 1 (HIV-1) promoter in central nervous system cells: effect of YB-1 on expression of the HIV-1 long terminal repeat.
    Sawaya BE, Khalili K, Amini S.
    J Gen Virol; 1998 Feb; 79 ( Pt 2)():239-46. PubMed ID: 9472608
    [Abstract] [Full Text] [Related]

  • 5. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F, Shibata R, Ross EK, Brady JN, Martin MA.
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [Abstract] [Full Text] [Related]

  • 6. Binding of NF-kB to the HIV-1 LTR is not sufficient to induce HIV-1 LTR activity.
    Doppler C, Schalasta G, Amtmann E, Sauer G.
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):245-52. PubMed ID: 1540410
    [Abstract] [Full Text] [Related]

  • 7. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
    Majello B, De Luca P, Hagen G, Suske G, Lania L.
    Nucleic Acids Res; 1994 Nov 25; 22(23):4914-21. PubMed ID: 7800480
    [Abstract] [Full Text] [Related]

  • 8. Basal and Tat-transactivated expression from the human immunodeficiency virus type 1 long terminal repeat in human placental trophoblast rules out promoter-enhancer activation as the partial block to viral replication.
    Zachar V, Ebbesen P, Thomas RA, Zacharova V, Goustin AS.
    J Gen Virol; 1994 Jun 25; 75 ( Pt 6)():1461-8. PubMed ID: 8207411
    [Abstract] [Full Text] [Related]

  • 9. Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein.
    Zhang JL, Sharma PL, Crumpacker CS.
    Virology; 2000 Mar 15; 268(2):251-63. PubMed ID: 10704334
    [Abstract] [Full Text] [Related]

  • 10. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER, Alcamí J, López M, Soriano V, Holguín A.
    Antiviral Res; 2010 Nov 15; 88(2):152-9. PubMed ID: 20713090
    [Abstract] [Full Text] [Related]

  • 11. Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 Tax protein is through cooperation of NF-kappaB and Tat.
    Cheng H, Tarnok J, Parks WP.
    J Virol; 1998 Aug 15; 72(8):6911-6. PubMed ID: 9658145
    [Abstract] [Full Text] [Related]

  • 12. NFAT1 enhances HIV-1 gene expression in primary human CD4 T cells.
    Cron RQ, Bartz SR, Clausell A, Bort SJ, Klebanoff SJ, Lewis DB.
    Clin Immunol; 2000 Mar 15; 94(3):179-91. PubMed ID: 10692237
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.
    Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human immunodeficiency virus type 1 replication by a Tat-activated, transduced interferon gene: targeted expression to human immunodeficiency virus type 1-infected cells.
    Su Y, Popik W, Pitha PM.
    J Virol; 1995 Jan 01; 69(1):110-21. PubMed ID: 7983701
    [Abstract] [Full Text] [Related]

  • 15. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
    Taylor JP, Pomerantz RJ, Oakes JW, Khalili K, Amini S.
    Oncogene; 1995 Jan 19; 10(2):395-400. PubMed ID: 7838536
    [Abstract] [Full Text] [Related]

  • 16. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
    Vlach J, Garcia A, Jacqué JM, Rodriguez MS, Michelson S, Virelizier JL.
    Virology; 1995 Apr 20; 208(2):753-61. PubMed ID: 7747447
    [Abstract] [Full Text] [Related]

  • 17. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms.
    Chang LJ, McNulty E, Martin M.
    J Virol; 1993 Feb 20; 67(2):743-52. PubMed ID: 8419644
    [Abstract] [Full Text] [Related]

  • 18. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ, Zhang C.
    Virology; 1995 Aug 01; 211(1):157-69. PubMed ID: 7645208
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism.
    Kinter AL, Biswas P, Alfano M, Justement JS, Mantelli B, Rizzi C, Gatti AR, Vicenzi E, Bressler P, Poli G.
    Mol Med; 2001 Oct 01; 7(10):668-78. PubMed ID: 11713366
    [Abstract] [Full Text] [Related]

  • 20. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
    Jeyaseelan R, Kurabayashi M, Kedes L.
    AIDS Res Hum Retroviruses; 1996 May 01; 12(7):569-76. PubMed ID: 8743082
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.